Vaishali Sanchorawala, MBBS

Professor, Medicine

Vaishali Sanchorawala
732 Harrison Ave

Biography

Expertise includes: AL amyloidosis – clinical trials, treatment; Stem cell transplantation; Myeloma.

Other Positions

  • Director, Amyloidosis Center, Boston University School of Medicine
  • Active Staff Hospital Privileges, Medicine, Boston Medical Center

Education

  • Seth G.S. Medical College, MBBS

Classes Taught

Publications

  • Published on 6/19/2018

    Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified high-dose melphalan and autologous stem cell transplantation for AL amyloidosis: Experience in 334 patients. Biol Blood Marrow Transplant. 2018 Jun 19. PMID: 29933072.

    Read at: PubMed
  • Published on 6/14/2018

    Sarosiek S, Quillen K, Sloan JM, Brauneis D, Sanchorawala V. Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation. Blood. 2018 Jun 14. PMID: 29903887.

    Read at: PubMed
  • Published on 6/8/2018

    White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S, Sanchorawala V. High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone Marrow Transplant. 2018 Jun 08. PMID: 29884854.

    Read at: PubMed
  • Published on 5/1/2018

    Siddiqi OK, Sanchorawala V, Ruberg FL. Echocardiography and Survival in Light Chain Cardiac Amyloidosis: Back to Basics. Circ Cardiovasc Imaging. 2018 May; 11(5):e007826. PMID: 29752394.

    Read at: PubMed
  • Published on 4/26/2018

    Pudusseri A, Smith I, Sarnacki D, Brauneis D, Shelton A, Sanchorawala V, Sloan JM, Sarosiek S, Quillen K. Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients. Transfus Apher Sci. 2018 Apr 26. PMID: 29731423.

    Read at: PubMed
  • Published on 4/1/2018

    Ding Y, Francis J, Gautam A, Pelletier L, Sanchorawala V, Quillen K. Durable renal response after combination of bortezomib, corticosteroids, rituximab, and plasmapheresis for late antibody-mediated renal transplant rejection?. Clin Nephrol. 2018 Apr; 89(4):252-259. PMID: 29208204.

    Read at: PubMed
  • Published on 3/8/2018

    Jhaveri T, Sarosiek S, Ruberg FL, Siddiqi O, Berk JL, Sanchorawala V. Once AL amyloidosis: not always AL amyloidosis. Amyloid. 2018 Mar 08; 1-2. PMID: 29516761.

    Read at: PubMed
  • Published on 2/24/2018

    Havasi A, Doros G, Sanchorawala V. Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation. Am J Hematol. 2018 May; 93(5):E129-E132. PMID: 29430701.

    Read at: PubMed
  • Published on 2/9/2018

    Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, Sarosiek S. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Amyloid. 2018 Mar; 25(1):62-67. PMID: 29424556.

    Read at: PubMed
  • Published on 1/5/2018

    Hari P, Lin HM, Asche CV, Ren J, Yong C, Luptakova K, Faller DV, Sanchorawala V. Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis. Amyloid. 2018 Mar; 25(1):1-7. PMID: 29303358.

    Read at: PubMed

View 114 more publications: View full profile at BUMC

View all profiles